Who has invested in Jacobio Pharmaceuticals?

Lilly Asia Ventures, Qiming Venture Partners, Hillhouse are named among the investors backing Jacobio Pharmaceuticals.

Jacobio Pharmaceuticals Funding: $200M Raised, Series C

Jacobio Pharmaceuticals funding overview

Jacobio Pharmaceuticals is based in Beijing, China. Jacobio Pharmaceuticals has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C. Investors on record include Lilly Asia Ventures, Qiming Venture Partners, Hillhouse. 3 distinct backers are named across the disclosed rounds.

Jacobio Pharmaceuticals at a glance

Total raised: $200M
Latest round: Series C
Headquarters: Beijing, China
Notable investors: Lilly Asia Ventures, Qiming Venture Partners, Hillhouse

Frequently asked about Jacobio Pharmaceuticals funding

How much has Jacobio Pharmaceuticals raised?: Jacobio Pharmaceuticals has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Jacobio Pharmaceuticals?: Lilly Asia Ventures, Qiming Venture Partners, Hillhouse are named among the investors backing Jacobio Pharmaceuticals.
What was the latest Jacobio Pharmaceuticals funding round?: The most recent disclosed round is a Series C.
Where is Jacobio Pharmaceuticals based?: Jacobio Pharmaceuticals is based in Beijing, China.

Every Jacobio Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Beijing at a similar stage.

Jacobio Pharmaceuticals Funding: $200M Raised, Series C

Jacobio Pharmaceuticals funding overview

Jacobio Pharmaceuticals at a glance

Frequently asked about Jacobio Pharmaceuticals funding

Companies related to Jacobio Pharmaceuticals (36)

Browse related funding lists (7)